Related Experiment Videos
Intrapericardial triamcinolone hexacetonide in the treatment of intractable uremic pericarditis in a child
1Department of Pediatrics, University of Maryland School of Medicine, Baltimore 21201.
Insights
Uremic pericarditis in children on dialysis is challenging to treat. Intrapericardial triamcinolone offers a successful novel therapeutic option for managing pericardial effusion in this patient group.
Area of Science:
- Pediatric Nephrology
- Cardiology
Background:
- Uremic pericarditis is a serious complication in children undergoing chronic hemodialysis.
- Standard treatments often yield limited success, posing a significant management challenge.
Observation:
- A 10-year-old anephric boy on chronic dialysis presented with uremic pericarditis.
- The patient required vigorous medical therapy and consideration for surgical intervention.
Findings:
- Successful management of uremic pericarditis was achieved using intrapericardial triamcinolone.
- The report details the specific technique employed for administration.
Implications:
- Intrapericardial triamcinolone represents a promising therapeutic strategy for pediatric uremic pericarditis.
- This approach may offer an alternative to surgical drainage in select cases.
Abstract:
Uremic pericarditis in children on chronic hemodialysis represents a difficult management problem, necessitating vigorous medical therapy and often surgical drainage of the pericardial effusion. Standard therapeutic approaches have met with limited success. The successful use of intrapericardial triamcinolone in a 10-year anephric boy on chronic dialysis is reported and accompanied by a description of the technique applied and literature review.